Wellfully : Investor Webinar Presentation

ersonal use only

INVESTOR CALL

16 FEBRUARY 2022

PAUL PEROS

DISCLAIMER

use only
This presentation contains certain "forward-looking statements" concerning Wellfully. Where Wellfully expresses or implies an expectation or belief as to
ersonal
future events or results, such expectation or belief is expressed in good faith and believed to have a reasonable basis.
Forward-looking statements provided in this announcement are based on assumptions and contingencies which are subject to change without notice.
Such forward-looking statements including statements regarding intentions, planned events and potential results are provided as a general guide only
a d should not be relied upon as an indication or guarantee of future performance.
There can be no assurance that actual outcomes will not differ materially from these forward-looking statements, and there are risks associated with
Wellfully and the industry which may affect the accuracy of the forward-looking statements. Wellfully does not undertake any obligation to release
publicly any revisions to any forward-looking statements to reflect events or circumstances after the date of this announcement or to reflect the
occurrence of unanticipated events, except as may be required under applicable securities laws.
ASX:WFL - Feb 2022	2

WELLFULLY CORPORATE SNAPSHOT

AN INNOVATIVE WELLNESS COMPANY WITH GLOBALLY DISRUPTIVE PRODUCTS

About Wellfully Limited (ASX:WFL)

Wellfully Limited ('Wellfully' or 'the Company') is the world's first fully-integrated,

onlyscience-based wellness company. Over the past two years, the Company has

leveraged its vast enhanced drug deliveries technology inventory and developed industrial infrastructure and its own product portfolio.

Wellfully is active in the highly attractive beauty and personal care, beauty device, as well as the health and pain relief markets delivering innovative products through c llaborations with industry majors spanning licensing, joint development and OEM. Additionally, the Company has launched its own global cosmetic and healthcare brands, RÉDUIT and SWISSWELL, which are positioned to disrupt blockbuster global

markets.
use
Supported by a highly experienced Board and Management, Wellfully is poised to
d liver notable and sustainable results.
Corporate Snapshot*
	Share Price	$0.068
ersonal
	Shares on Issue	~249.8m
	Options on Issue	~165.1m
	Market Capitalisation	~$17.0m
	Top 20	35.9%
	Board & Management	9.3%

*Share price, market capitalisation, share holdings as at 15 February 2022 ASX:WFL - Feb 2022

Share Price Performance

	25	0.2
		0.18
	20	0.16
		0.14
(M)	15	0.12	(A$/Sh)
Volume		0.1	Share Price
10	0.08
		0.06
	5	0.04
		0.02
	0	0

.21		.21	1	1	1	.21	1	.21	.21	1		1			.
	.2	.2	.2	.2	.2	.2 .
Feb	r	Apr	y	Jun	Jul	Aug	Sep	Oct	Nov	Dec		n	22	Feb	22
Ma
	Ma		Ja
								Volume		Share Price

3

AGENDA

INVESTOR CALL

onlyuse	INTRODUCTION
ersonal
ASX:WFL - Feb 2022	4

The shift from technology licensing to own brands and products is gaining momentum

INTEGRATED BUSINESS DEVELOPMENT

TOP LINE DEVELOPMENT FOR THE FY 2020-2021 AND 2022 YTD PERIOD

Revenues, k$

only	1'600
1'200	577	205
use	800		258
			1'195
400	907
	740
0				54
ersonal
			FY 2020		FY 2021		FY 2022 YTD*
		R&D subsidies		Tech licensing		Own products & brands

*Non-audited revenues for the 6 months from July 1 to December 31, 2021 ASX:WFL - Feb 2022

Own brands and products

Without R&D subsidies, the revenues in the first 6 months of FY2022 were dominated by own product and brand sales, surpassing the total revenues of the past two years combined by over 20%

Note: the R&D subsidies for FY2022 are expected H2.

5